Overview of Dr. Sweet-Cordero
I am a physician-scientist and cancer biologist. I am board-certified in pediatric oncology and I direct the UCSF Molecular Oncology Initiative.
Office
725 Welch Rd
Palo Alto, CA 94304
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1999 - 2002
- University of California (San Francisco)Residency, Pediatrics, 1995 - 1998
- University of California San Francisco School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 1997 - 2025
- MA State Medical License 1999 - 2006
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Member, American Society for Clinical Investigation ASCI, 2011
Publications & Presentations
PubMed
- 166 citationsLoss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung CarcinomaBethany E. Schaffer, Kwon-Sik Park, Gloria Yiu, Jamie F. Conklin, Chenwei Lin
Cancer Research. 2010-05-15 - 46 citationsAntitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma.Kim Jun Woo, Cesar P Marquez, Kaja Kostyrko, Amanda Koehne, Kieren D. Marini
Nature Medicine. 2019-11-01 - 154 citationsOncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-AsparaginaseDana Gwinn, Alexander Lee, Marcela Briones-Martin-del-Campo, Crystal S. Conn, David R. Simpson
Cancer Cell. 2018-01-08
Press Mentions
- AACR Research Highlights from UCSFApril 6th, 2022
- Upcoming AACR Virtual Meeting on Sarcomas Spotlights Early-Career ResearchersJune 24th, 2021
- Protein Decoy Stymies Lung Cancer Growth in Stanford-UCSF StudyNovember 7th, 2019
Grant Support
- Mechanisms Of Chemotherapy Response And Tumor Re-Initiation In Lung CancerNational Cancer Institute2011–2012
- Comparative Functional Genomics For Lung Cancer Gene DiscoveryNational Cancer Institute2008–2011
- Identification Of Novel KRAS Effector Pathways In Lung CancerNational Cancer Institute2009–2010
- Tumor Progression In A Mouse Model Of Lung CancerNational Cancer Institute2005–2007
- Tumor Progression In A Mouse Model Of Lung CancerNational Cancer Institute2003–2004
External Links
- lab websitehttps://sweetcorderolab.ucsf.edu/
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California PPO
BCBS Georgia Blue Choice HMO
BCBS Georgia Blue Open Access POS
BCBS Georgia BlueChoice Option POS
BCBS Illinois BlueChoice Select
BCBS Illinois PPO
Capital Blue Cross PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
Great West PPO
Health Net California Large Group PPO
Highmark BCBS ClassicBlue
Highmark BCBS PPOBlue
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: